FERRERA, ARMANDO
FERRERA, ARMANDO
Anthracyclines-Induced Cardiac Dysfunction. What Every Clinician Should Know
2023 Ferrera, A.; Fiorentini, V.; Reale, S.; Solfanelli, G.; Tini, G.; Barbato, E.; Volpe, M.; Battistoni, A.
Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk. Another Brick in the Wall
2024 Piras Michela Zuccanti, Linda; Russo, Paola; Riccio, Francesca; Agresti, Antonio; Lustri, Camilla; Dardani, Domenico; Ferrera, Armando; Fiorentini, Vincenzo; Tocci, Giuliano; TINI MELATO, Giacomo; Volpe, Massimo; Barbato, Emanuele; Battistoni, Allegra
Atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac amyloidosis: from clinical management to catheter ablation indication
2024 Mistrulli, Raffaella; Ferrera, Armando; Muthukkattil, Melwyn Luis; Battistoni, Allegra; Gallo, Giovanna; Barbato, Emanuele; Spera, Francesco Raffaele; Magri, Damiano
Comparison of cardiovascular risk scores to predict anthracycline-induced cardiotoxicity in early breast cancer patients
2021 Solfanelli, G; Bianchini, G; Petrungaro, M; Reale, S; Lanza, O; Ferrera, A; Tini, G; Piras, M; Pellegrini, P; Tocci, G; Battistoni, A; Volpe, M
Low Perception of Obesity as a Pathological Condition Among Italian Cardiologists
2023 Ferrera, Armando; Battistoni, Allegra; Lanza, Oreste; Rossi, Chiara; Tocci, Giuliano; Volpe, Massimo
New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies
2022 Lanza, Oreste; Ferrera, Armando; Reale, Simone; Solfanelli, Giorgio; Petrungaro, Mattia; TINI MELATO, Giacomo; Volpe, Massimo; Battistoni, Allegra
Obesity and Overweight: The “Elephant in the Room” That We can No Longer Ignore: Time to SELECT Treatments
2024 Ferrera, Armando; Gallo, Giovanna; Volpe, Massimo
Obesity: an overlooked player in cardiological practice and the need for urgent action
2024 Ferrera, Armando; Battistoni, Allegra; Volpe, Massimo
SARS-CoV-2 Related Myocarditis. What We Know So Far
2023 Mistrulli, Raffaella; Ferrera, Armando; Muthukkattil, Melwyn Luis; Volpe, Massimo; Barbato, Emanuele; Battistoni, Allegra
The Emerging Role of Prediabetes and Its Management. Focus on l-Arginine and a Survey in Clinical Practice
2023 Volpe, Massimo; Ferrera, Armando; Piccinocchi, Roberto; Morisco, Carmine
{MICROVASCULAR} {ANGINA} {IS} {ASSOCIATED} {WITH} {SYSTEMIC} {DYSFUNCTION} {OF} {PERIPHERAL} {RESISTANCE} {ARTERIES}
2021 Michielon, Alberto; Lanza, Oreste; Ingrasciotta, Gesssica; Ferrera, Armando; Cesario, Vincenzo; Marino, Gaetano; Ruscio, Eleonora; Filice, Monica; De Vita, Antonio; Crea, Filippo; Volpe, Massimo; Lanza, Gaetano A.; Savoia, Carmine
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anthracyclines-Induced Cardiac Dysfunction. What Every Clinician Should Know | 2023 | Ferrera, A.; Fiorentini, V.; Reale, S.; Solfanelli, G.; Tini, G.; Barbato, E.; Volpe, M.; Battistoni, A. | |
| Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk. Another Brick in the Wall | 2024 | Piras Michela Zuccanti, Linda; Russo, Paola; Riccio, Francesca; Agresti, Antonio; Lustri, Camilla; Dardani, Domenico; Ferrera, Armando; Fiorentini, Vincenzo; Tocci, Giuliano; TINI MELATO, Giacomo; Volpe, Massimo; Barbato, Emanuele; Battistoni, Allegra | |
| Atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac amyloidosis: from clinical management to catheter ablation indication | 2024 | Mistrulli, Raffaella; Ferrera, Armando; Muthukkattil, Melwyn Luis; Battistoni, Allegra; Gallo, Giovanna; Barbato, Emanuele; Spera, Francesco Raffaele; Magri, Damiano | |
| Comparison of cardiovascular risk scores to predict anthracycline-induced cardiotoxicity in early breast cancer patients | 2021 | Solfanelli, G; Bianchini, G; Petrungaro, M; Reale, S; Lanza, O; Ferrera, A; Tini, G; Piras, M; Pellegrini, P; Tocci, G; Battistoni, A; Volpe, M | |
| Low Perception of Obesity as a Pathological Condition Among Italian Cardiologists | 2023 | Ferrera, Armando; Battistoni, Allegra; Lanza, Oreste; Rossi, Chiara; Tocci, Giuliano; Volpe, Massimo | |
| New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies | 2022 | Lanza, Oreste; Ferrera, Armando; Reale, Simone; Solfanelli, Giorgio; Petrungaro, Mattia; TINI MELATO, Giacomo; Volpe, Massimo; Battistoni, Allegra | |
| Obesity and Overweight: The “Elephant in the Room” That We can No Longer Ignore: Time to SELECT Treatments | 2024 | Ferrera, Armando; Gallo, Giovanna; Volpe, Massimo | |
| Obesity: an overlooked player in cardiological practice and the need for urgent action | 2024 | Ferrera, Armando; Battistoni, Allegra; Volpe, Massimo | |
| SARS-CoV-2 Related Myocarditis. What We Know So Far | 2023 | Mistrulli, Raffaella; Ferrera, Armando; Muthukkattil, Melwyn Luis; Volpe, Massimo; Barbato, Emanuele; Battistoni, Allegra | |
| The Emerging Role of Prediabetes and Its Management. Focus on l-Arginine and a Survey in Clinical Practice | 2023 | Volpe, Massimo; Ferrera, Armando; Piccinocchi, Roberto; Morisco, Carmine | |
| {MICROVASCULAR} {ANGINA} {IS} {ASSOCIATED} {WITH} {SYSTEMIC} {DYSFUNCTION} {OF} {PERIPHERAL} {RESISTANCE} {ARTERIES} | 2021 | Michielon, Alberto; Lanza, Oreste; Ingrasciotta, Gesssica; Ferrera, Armando; Cesario, Vincenzo; Marino, Gaetano; Ruscio, Eleonora; Filice, Monica; De Vita, Antonio; Crea, Filippo; Volpe, Massimo; Lanza, Gaetano A.; Savoia, Carmine |